Medidata Launches Decentralized Clinical Trials Program
NEW YORK, NY, USA, Jun 17, 2021 – Medidata, a Dassault Systèmes company, today announced the launch of the Medidata Decentralized Clinical Trials (DCT) Program, the most comprehensive set of unified, secure technologies that enable full decentralization across the clinical trial continuum. For the first time ever, drug, vaccine, and medical device developers (sponsors) and […]
Medidata Launches Decentralized Clinical Trials Program
2021-06-17 22:01